AstraZeneca is one of only a handful of pure-play biopharmaceutical companies to span the entire value chain of a medicine from discovery, early- and late-stage development to manufacturing and distribution, and the global commercialisation of primary care, specialty care-led and specialty care medicines that transform lives.

Our primary focus is on three important areas of healthcare: Cardiovascular and Metabolic disease (CVMD); Oncology; and Respiratory, Inflammation and Autoimmunity (RIA). We are also active in the Infection, Neuroscience and Gastrointestinal (ING) disease areas.

Key facts
  • We employ around 51,500 people worldwide: 34.8% in Europe, 21.7% in North America, 6% in Central and South America, 4.1% in the Middle East and Africa and 33.4% in Asia Pacific.
  • We manufacture in 16 countries and are committed to ensuring a reliable supply of medicines where and when they are needed.
  • We work in over 100 countries and our medicines are used by millions of patients worldwide.
  • Our sales in 2012 totalled $25.7 billion

More facts are available in our 2013 Annual Report.

distributed by